Abstract:Objective To investigate the role of calreticulin (CRT) in the diagnosis and assessment of disease activity in the patients with early rheumatoid arthritis (RA). Methods Serum CRT level was measured by ELISA in 45 patients with early RA, 35 cases with osteoarthritis (OA) and 30 healthy controls (HC). ESR was measured by the Westergren method. Serum CRP level was measured by immunonephelometry. The correlations of CRT with Disease Activity Score for 28 joints (DAS28 score), ESR and CRP were assessed by Spearman's rank correlation coefficient. Results The serum concentration of CRT of the early RA patients[(6.7 ±2.5) μg/L] was higher than that of the OA patients and HC [(3.9 ±0.9) and (3.8 ±0.7) μg/L,P < 0.05],while there was no significant difference between the OA and HC groups (P > 0.05). Compared with the OA and HC groups, the ESR and CRP levels were elevated in the early RA group (P < 0.05). Serum CRT concentration in the early RA patients was positively correlated with DAS28 score, ESR and CRP ( rs=0.391,0.459 and 0.454;P = 0.008, 0.002 and 0.002). Conclusions Together with ESR and CRP, CRT may be used as a potential biomarker for early diagnosis of RA and for assessment of disease activity.